Companies · Other Health Care

TypeZero Technologies LLC

CHARLOTTESVILLE · Other Health Care

Diligence memoA one-page analyst read on TypeZero Technologies LLC — recommendation, valuation, rhythm, risks.
$415K
Total raised · real
1
Rounds
Latest step-up
Top 83%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

TypeZero Technologies LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.28× the median modeled value of Pre-Seed Other Health Care companies in 2013–2015 (343 peers) — value vs value, same stage and era.
  • Within the normal band (128% of peer median) for its niche.
Dormant
  • Last raise 11.1 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

TypeZero Technologies LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
11.1 yr record
Peak capital year was 2015 with $415K across 1 filings.
Market position
ahead of 18% of Other Health Care peers
Capital scale is ahead of 18% of Other Health Care peers; modeled value is above 39% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2015: $415K across 1 filings.
  • Largest single filing was $415K on 2015-05-26.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

TypeZero Technologies LLC is one of 5376 Other Health Care companies tracked from CHARLOTTESVILLE. By capital raised it ranks in the long tail (ahead of 18% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2015-05-26 Raised $415K (real) Modeled valuation $13M (est)$415K$13MPre-Seed2015

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$415K · 2015

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$12.8M
Base estimate est.
$260K
Conservative case
$145.0M
Upside case
$2.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
6.0 yr
Elapsed time used
11.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
11.1 yr
On record since
2015
First round
1
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.2× of median
This company$415K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 1.2× above median
This company$415K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.6× of median
This company$12.8M
Sector median$22.1M

Raised more than 18% of sector peers (real $). Modeled value above 39% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #138 of 343.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Optimized Care Network, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Sensiotec Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)In2Bones Usa, Llc · Pre-Seed Raised $1.0M · modeled $30.8M (est)Medinvus, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)ERG Holding Company, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Phoenix Clinical Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)Versaworks, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)Nath Holdings, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)PSI Premier Specialties, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)SKYMEDICUS, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)Pure Life Renal LLC · Pre-Seed Raised $1.5M · modeled $30.8M (est)Ludi, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)TypeZero Technologies LLC (this company) Raised $415K · modeled $12.8M (est)TypeZero Technologies LLC
CompanyStageRaised · realValue · estvs peer med.
Optimized Care Network, LLCPre-Seed$1.0M$30.8M3.08×
Sensiotec Inc.Pre-Seed$1.0M$30.8M3.08×
In2Bones Usa, LlcPre-Seed$1.0M$30.8M3.08×
Medinvus, LLCPre-Seed$1.0M$30.8M3.08×
ERG Holding Company, LLCPre-Seed$1.0M$30.8M3.08×
Phoenix Clinical Inc.Pre-Seed$1.0M$30.8M3.08×
Versaworks, Inc.Pre-Seed$1.0M$30.8M3.08×
Nath Holdings, LLCPre-Seed$1.0M$30.8M3.08×
PSI Premier Specialties, Inc.Pre-Seed$1.0M$30.8M3.08×
SKYMEDICUS, Inc.Pre-Seed$1.0M$30.8M3.08×
Pure Life Renal LLCPre-Seed$1.5M$30.8M3.08×
Ludi, Inc.Pre-Seed$1.0M$30.8M3.08×
TypeZero Technologies LLC this companyPre-Seed$415K$12.8M1.28×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$415K2015-05-26$2.3M$12.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$415K2015-05-26
    • First recorded raise — entered as Pre-Seed.
Intelligence
Modeled next raise
$664K
Modeled next size est.range $432K$1.1M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Boris T Kovatchev2015-05
Lee Chadwick Rogers2015-05
Marc D Breton2015-05
Patrick T Keith-Hynes2015-05
Stephen D Patek2015-05
Registry & provenance

TypeZero Technologies LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1645346
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Sadiant LLCOther Health CarePre-Seed$415K$12.8Msame sector · same stage
Fresenius Medical Care SW Jackson Home, LLCOther Health CarePre-Seed$413K$12.7Msame sector · same stage
Novamed Eye Surgery Center Of New Albany LlcOther Health CarePre-Seed$413K$12.7Msame sector · same stage
Focused Genomics, Inc.Other Health CarePre-Seed$420K$12.9Msame sector · same stage
Las Cruces Surgery Center, L.P.Other Health CarePre-Seed$421K$13.0Msame sector · same stage
Ankota, Inc.Other Health CarePre-Seed$425K$13.1Msame sector · same stage
Restore Holdings, LLCOther Health CarePre-Seed$425K$13.1Msame sector · same stage
USRC Stephenville, LLCOther Health CarePre-Seed$405K$12.5Msame sector · same stage
Frequently asked
How much funding has TypeZero Technologies LLC raised?
TypeZero Technologies LLC has raised approximately $415K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is TypeZero Technologies LLC's estimated valuation?
Provath's modeled valuation for TypeZero Technologies LLC is approximately $12.8M (modeled range $260K–$145.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is TypeZero Technologies LLC at?
TypeZero Technologies LLC's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Tue May 26.
What does TypeZero Technologies LLC do and where is it based?
TypeZero Technologies LLC operates in the Other Health Care sector, based in CHARLOTTESVILLE.
Explore related

See where TypeZero Technologies LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at TypeZero Technologies LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.